FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386453320> ?p ?o ?g. }

• W4386453320 endingPage "858" @default.
• W4386453320 startingPage "857" @default.
• W4386453320 abstract "HomeCirculationVol. 148, No. 10Response by Aronsen et al to Letter Regarding Article, “Disruption of Phosphodiesterase 3A Binding to SERCA2 Increases SERCA2 Activity and Reduces Mortality in Mice With Chronic Heart Failure” No AccessLetterRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessLetterRequest AccessFull TextResponse by Aronsen et al to Letter Regarding Article, “Disruption of Phosphodiesterase 3A Binding to SERCA2 Increases SERCA2 Activity and Reduces Mortality in Mice With Chronic Heart Failure” Jan Magnus Aronsen, Jonas Skogestad, Ingrid Albert, Arne Olav Melleby and Cathrine R. Carlson Jan Magnus AronsenJan Magnus Aronsen https://orcid.org/0000-0003-2593-1744 Department of Molecular Medicine, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Norway (J.M.A., J.S., A.O.M.). Department of Pharmacology, Oslo University Hospital, Rikshospitalet, Norway (J.M.A., J.S.). Search for more papers by this author , Jonas SkogestadJonas Skogestad Department of Molecular Medicine, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Norway (J.M.A., J.S., A.O.M.). Department of Pharmacology, Oslo University Hospital, Rikshospitalet, Norway (J.M.A., J.S.). Search for more papers by this author , Ingrid AlbertIngrid Albert Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Norway (I.A., C.R.C.). Search for more papers by this author , Arne Olav MellebyArne Olav Melleby https://orcid.org/0000-0002-3524-8829 Department of Molecular Medicine, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Norway (J.M.A., J.S., A.O.M.). Search for more papers by this author and Cathrine R. CarlsonCathrine R. Carlson https://orcid.org/0000-0001-6360-3149 Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Norway (I.A., C.R.C.). Search for more papers by this author Originally published5 Sep 2023https://doi.org/10.1161/CIRCULATIONAHA.123.065884Circulation. 2023;148:857–858Response by Aronsen et al to Letter Regarding Article, “Disruption of Phosphodiesterase 3A Binding to SERCA2 Increases SERCA2 Activity and Reduces Mortality in Mice With Chronic Heart Failure”. Circulation, 148(10), pp. 857–858FootnotesCirculation is available at www.ahajournals.org/journal/circREFERENCES1. Skogestad J, Albert I, Hougen K, Lothe GB, Lunde M, Søvik Eken O, Veras I, Thi Huynh NT, Børstad M, Marshall S, et al. Disruption of phosphodiesterase 3A binding to SERCA2 increases SERCA2 activity and reduces mortality in mice with chronic heart failure.Circulation. 2023; 147:1221–1236. doi: 10.1161/CIRCULATIONAHA.121.054168LinkGoogle Scholar2. Toyoshima C, Iwasawa S, Ogawa H, Hirata A, Tsueda J, Inesi G. Crystal structures of the calcium pump and sarcolipin in the Mg2+-bound E1 state.Nature. 2013; 495:260–264. doi: 10.1038/nature11899CrossrefMedlineGoogle Scholar3. Kiriazis H, Sato Y, Kadambi VJ, Schmidt AG, Gerst MJ, Hoit BD, Kranias EG. Hypertrophy and functional alterations in hyperdynamic phospholamban-knockout mouse hearts under chronic aortic stenosis.Cardiovas Res. 2002; 53:372–381. doi: 10.1016/s0008-6363(01)00487-4CrossrefMedlineGoogle Scholar4. Miyamoto MI, del Monte F, Schmidt U, DiSalvo TS, Kang ZB, Matsui T, Guerrero JL, Gwathmey JK, Rosenzweig A, Hajjar RJ. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure.Proc Natl Acad Sci U S A. 2000; 97:793–798. doi: 10.1073/pnas.97.2.793CrossrefMedlineGoogle Scholar5. Ghionzoli N, Gentile F, Del Franco AM, Castiglione V, Aimo A, Giannoni A, Burchielli S, Cameli M, Emdin M, Vergaro G. Current and emerging drug targets in heart failure treatment.Heart Fail Rev. 2022; 27:1119–1136. doi: 10.1007/s10741-021-10137-2CrossrefMedlineGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetails September 5, 2023Vol 148, Issue 10 Advertisement Article InformationMetrics © 2023 American Heart Association, Inc.https://doi.org/10.1161/CIRCULATIONAHA.123.065884PMID: 37669357 Originally publishedSeptember 5, 2023 PDF download Advertisement SubjectsPrognosisStentThrombosis" @default.
• W4386453320 created "2023-09-06" @default.
• W4386453320 creator A5018742894 @default.
• W4386453320 creator A5040270788 @default.
• W4386453320 creator A5061096455 @default.
• W4386453320 creator A5077462468 @default.
• W4386453320 creator A5077522155 @default.
• W4386453320 date "2023-09-05" @default.
• W4386453320 modified "2023-09-30" @default.
• W4386453320 title "Response by Aronsen et al to Letter Regarding Article, “Disruption of Phosphodiesterase 3A Binding to SERCA2 Increases SERCA2 Activity and Reduces Mortality in Mice With Chronic Heart Failure”" @default.
• W4386453320 cites W2042961764 @default.
• W4386453320 cites W2048303185 @default.
• W4386453320 cites W2145537234 @default.
• W4386453320 cites W3177958975 @default.
• W4386453320 cites W4323294855 @default.
• W4386453320 doi "https://doi.org/10.1161/circulationaha.123.065884" @default.
• W4386453320 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37669357" @default.
• W4386453320 hasPublicationYear "2023" @default.
• W4386453320 type Work @default.
• W4386453320 citedByCount "0" @default.
• W4386453320 crossrefType "journal-article" @default.
• W4386453320 hasAuthorship W4386453320A5018742894 @default.
• W4386453320 hasAuthorship W4386453320A5040270788 @default.
• W4386453320 hasAuthorship W4386453320A5061096455 @default.
• W4386453320 hasAuthorship W4386453320A5077462468 @default.
• W4386453320 hasAuthorship W4386453320A5077522155 @default.
• W4386453320 hasConcept C71924100 @default.
• W4386453320 hasConceptScore W4386453320C71924100 @default.
• W4386453320 hasIssue "10" @default.
• W4386453320 hasLocation W43864533201 @default.
• W4386453320 hasLocation W43864533202 @default.
• W4386453320 hasOpenAccess W4386453320 @default.
• W4386453320 hasPrimaryLocation W43864533201 @default.
• W4386453320 hasRelatedWork W1506200166 @default.
• W4386453320 hasRelatedWork W1995515455 @default.
• W4386453320 hasRelatedWork W2048182022 @default.
• W4386453320 hasRelatedWork W2080531066 @default.
• W4386453320 hasRelatedWork W2604872355 @default.
• W4386453320 hasRelatedWork W2748952813 @default.
• W4386453320 hasRelatedWork W2899084033 @default.
• W4386453320 hasRelatedWork W3031052312 @default.
• W4386453320 hasRelatedWork W3032375762 @default.
• W4386453320 hasRelatedWork W3108674512 @default.
• W4386453320 hasVolume "148" @default.
• W4386453320 isParatext "false" @default.
• W4386453320 isRetracted "false" @default.
• W4386453320 workType "article" @default.